Thursday, April 24
Clinical Science
Late-Breaking Clinical Trials 2025
Live Streaming
Clinical Science
Late-Breaking Clinical Trials 2025
Thursday, April 24
4:30 PM ~ 5:50 PM * KST (UTC/GMT +9:00)
Presentation Room 1, Level 1
Moderator(s): Gary S. Mintz, Alan C. Yeung
Panelist(s): Robert Thomas Gerber, John McB. Hodgson, Young Joon Hong, Weon Kim, Jinhyun Lee, Yves R. Louvard, Shigeru Nakamura
4:30 PM | TAVR Indication Expansion Trials: What Are Next? Lecturer: Philippe Genereux |
4:38 PM | Orbital Atherectomy vs. Conventional Balloon Angioplasty for Severe Calcified Lesion: ECLIPSE Trial Lecturer: Ajay J. Kirtane |
4:46 PM | Drug-Coated Balloon for Bifurcation Lesion: DCB-BIF Trial Lecturer: Shao-Liang Chen |
4:54 PM | Panel Discussion I |
5:04 PM | Key Findings of the FLAVOUR II Trial Lecturer: Jian'an Wang |
5:12 PM | Long-Term Final 5-Year Results of FAME-3 Trial Lecturer: William F. Fearon |
5:20 PM | Stratified Randomization Study to Compare Different Duration of Dual Antiplatelet Therapy After Coronary Stenting in Either High or Low Bleeding Risk Population: HOST-BR Trial Lecturer: Hyo-Soo Kim |
5:28 PM | Clopidogrel Versus Aspirin Monotherapy in High-Risk Patients After PCI: SMART-CHOICE 3 Trial Lecturer: Joo-Yong Hahn |
5:36 PM | Panel Discussion II |
Friday, April 25
Clinical Science
All About New Data From Asan Medical Center
Live Streaming
Clinical Science
All About New Data From Asan Medical Center
Friday, April 25
8:30 AM ~ 9:30 AM * KST (UTC/GMT +9:00)
Presentation Room 1, Level 1
Moderator(s): Javier Escaned, Eveline Regar
Panelist(s): Young Joon Hong, Seung-Ho Hur, Nils Johnson, Adnan Kastrati, Takashi Kubo, Cheol Hyun Lee, Rajinikanth Rajagopal, Toshiro Shinke
8:30 AM | Short- and Long-Term Effect of Cerebral Embolic Protection Device on New Brain Lesions Following Transcatheter Aortic-Valve Replacement: The Sentinel Registry Lecturer: Hansu Park |
8:38 AM | Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial Lecturer: Soo Yeon An |
8:46 AM | Impact of Antithrombotic Therapy Modification: Post Hoc Analysis of the EPIC CAD Trial Lecturer: Seongbong Wee |
8:54 AM | Antithrombotic Therapy in Diabetic Patients With Atrial Fibrillation and Stable Coronay Artery Disease: The EPIC-CAD Trial Lecturer: Seunghan Lee |
9:02 AM | Optical Coherence Tomography-Guided or Intravascular Ultrasound Guided PCI for In-Stent Restenosis Lesions in the OCTIVUS Trial Lecturer: Kyeongwon Seo |
9:10 AM | Panel Discussion |
Ongoing and Future RCTs From Asan Medical Center
Live Streaming
Clinical Science
Ongoing and Future RCTs From Asan Medical Center
Friday, April 25
9:40 AM ~ 11:10 AM * KST (UTC/GMT +9:00)
Presentation Room 1, Level 1
Moderator(s): William F. Fearon, Gary S. Mintz
Panelist(s): Kevin Bainey, So-Yeon Choi, James Flaherty, Alexander Goldberg, Ho Lam, Kenji Sadamatsu, Hyuck Jun Yoon
9:40 AM | RENOVATE Trial: DOAC vs. Warfarin for Mechanical Aortic Valve Prosthesis Lecturer: Joon Bum Kim |
9:48 AM | DEFINE-DM Trial: Imaging- and Physiology-Guided State-of-the-Art PCI vs. CABG for DM and Multi-Vessel Disease Lecturer: Duk-Woo Park |
9:56 AM | FATE-MAIN Trial: FFR- vs. Angiography-Guided Left Main PCI Lecturer: Seongbong Wee |
10:04 AM | VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD Lecturer: Do-Yoon Kang |
10:12 AM | Panel Discussion l |
10:25 AM | ASA-3C Trial: AcetylSalicylic Acid Use for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography Lecturer: Jung-Min Ahn |
10:33 AM | PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI Lecturer: Hansu Park |
10:41 AM | ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR Patients Lecturer: Soo Yeon An |
10:49 AM | TAILORED-CHIP Trial: Temporal Dynamic Antiplatelet Strategy for Complex High-Risk PCI Lecturer: Hanbit Park |
10:57 AM | Panel Discussion ll |
This program is subject to change without notice.